Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Pollard

Showing results (611-620 of 642) with videos related to

Pageof 65
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Journal of Surgical Oncology|August 1, 1982
Concurrent chemotherapy and radiation therapy of selected head and neck squamous cell carcinomas using bleomycin and hydroxyurea: A Southwest Oncology Group StudyA B Cruz, M Perkins, J B Aust, et al.
Journal of Occupational and Environmental Medicine|August 9, 2016
Introduction to Department of Defense Research on Burn Pits, Biomarkers, and Health Outcomes Related to Deployment in Iraq and AfghanistanCol Timothy M Mallon, Maj Patricia Rohrbeck, Maj Kevin M Haines, et al.
AIDS Research and Human Retroviruses|June 25, 2002
Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2Beverly E Sha, Hernan Valdez, Rebecca S Gelman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 19, 2008
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapyRichard T Davey, Peter E Pertel, Alice Benson, et al.
Lancet (London, England)|August 4, 2009
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialJeffrey L Lennox, Edwin DeJesus, Adriano Lazzarin, et al.
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Nature Medicine|July 15, 2009
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1Angela Meier, J Judy Chang, Ellen S Chan, et al.
Biological Psychiatry|December 23, 2023
Uncommon Protein-Coding Variants Associated With Suicide Attempt in a Diverse Sample of U.S. Army SoldiersMatthew D Wilkerson, Daniel Hupalo, Joshua C Gray, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 19, 2021
Rare variant association study of veteran twin whole-genomes links severe depression with a nonsynonymous change in the neuronal gene <i>BHLHE22</i>Daniel Hupalo, Christopher W Forsberg, Jack Goldberg, et al.
Pageof 65

Showing results (611-620 of 642) with videos related to

Sort By:
Pageof 65
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2004
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infectionCraig W Hendrix, Ann C Collier, Michael M Lederman, et al.
Journal of Surgical Oncology|August 1, 1982
Concurrent chemotherapy and radiation therapy of selected head and neck squamous cell carcinomas using bleomycin and hydroxyurea: A Southwest Oncology Group StudyA B Cruz, M Perkins, J B Aust, et al.
Journal of Occupational and Environmental Medicine|August 9, 2016
Introduction to Department of Defense Research on Burn Pits, Biomarkers, and Health Outcomes Related to Deployment in Iraq and AfghanistanCol Timothy M Mallon, Maj Patricia Rohrbeck, Maj Kevin M Haines, et al.
AIDS Research and Human Retroviruses|June 25, 2002
Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2Beverly E Sha, Hernan Valdez, Rebecca S Gelman, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 19, 2008
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapyRichard T Davey, Peter E Pertel, Alice Benson, et al.
Lancet (London, England)|August 4, 2009
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trialJeffrey L Lennox, Edwin DeJesus, Adriano Lazzarin, et al.
The Journal of Infectious Diseases|January 7, 1998
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study GroupJ E Feinberg, S Hurwitz, D Cooper, et al.
Nature Medicine|July 15, 2009
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1Angela Meier, J Judy Chang, Ellen S Chan, et al.
Biological Psychiatry|December 23, 2023
Uncommon Protein-Coding Variants Associated With Suicide Attempt in a Diverse Sample of U.S. Army SoldiersMatthew D Wilkerson, Daniel Hupalo, Joshua C Gray, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 19, 2021
Rare variant association study of veteran twin whole-genomes links severe depression with a nonsynonymous change in the neuronal gene <i>BHLHE22</i>Daniel Hupalo, Christopher W Forsberg, Jack Goldberg, et al.
Pageof 65